Literature DB >> 216701

Characterization of the apolipoprotein B polypeptide of human plasma low density lipoprotein in detergent and denaturation solutions.

J C Steele, J A Reynolds.   

Abstract

Apolipoprotein B, the polypeptide moiety of human serum low density lipoprotein, is subject to degradation (as evidenced by sodium dodecyl sulfate-polyacrylamide gel electrophoresis) both in the intact particle and after delipidation. Protease inhibitors, sodium azide, and nitrogen saturation did not influence the rate or degree of degradation. Lipid-free apolipoprotein B prepared by gel exclusion chromatography in sodium dodecyl sulfate bound a limited number of detergent molecules (up to 300) in monomeric sodium dodecyl sulfate solutions; circular dichroic spectra of this complex were similar to spectra of the intact lipoprotein. Near the critical micelle concentrations, a large, cooperative increase in detergent binding occurred, accompanied by circular dichroic changes indicating increased alpha helicity. By sucrose density centrifugation, lysopalmitoyl phosphatidylcholine could be substituted for the anionic detergent; about 300 mol of lysolipid were bound to the polypeptide. Replacement of detergent with guanidine hydrochloride by dialysis produced a soluble polypeptide with no ordered structure at denaturant concentrations above 7 M. At lower guanidine hydrochloride concentrations, structural elements were regained in a broad, reversible transition. It appears that apolipoprotein B is an easily degraded polypeptide with regions resembling water-soluble proteins but other regions which interact with lipid (or synthetic amphiphiles) and produce an overall insolubility in aqueous solution in the absence of amphiphilic ligands.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 216701

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Apolipoprotein B is conformationally flexible but anchored at a triolein/water interface: a possible model for lipoprotein surfaces.

Authors:  Libo Wang; Mary T Walsh; Donald M Small
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Development and partial characterisation of an antiserum against apolipoprotein B of the short-finned eel, Anguilla australis.

Authors:  Erin L Damsteegt; Hiroko Mizuta; Yuichi Ozaki; Naoshi Hiramatsu; Takashi Todo; Akihiko Hara; Shigeho Ijiri; Shinji Adachi; P Mark Lokman
Journal:  J Comp Physiol B       Date:  2014-03-11       Impact factor: 2.200

3.  Detection of unique antigenic determinants on human plasma low density lipoprotein and on delipidated apolipoprotein B.

Authors:  T S Watt; R M Watt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

4.  Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.

Authors:  J P Kane; D A Hardman; H E Paulus
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

5.  Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.

Authors:  E S Krul; M J Tikkanen; T G Cole; J M Davie; G Schonfeld
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis.

Authors:  Andreas Hermansson; Daniel F J Ketelhuth; Daniela Strodthoff; Marion Wurm; Emil M Hansson; Antonino Nicoletti; Gabrielle Paulsson-Berne; Göran K Hansson
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

7.  Methylamine-treated low density lipoproteins elicit different responses in HepG2 cells and macrophages.

Authors:  E Koren; N Dashti; P R Wilson; D M Lee
Journal:  Mol Cell Biochem       Date:  1993-07-07       Impact factor: 3.396

8.  Cloning and expression of apolipoprotein B, the major protein of low and very low density lipoproteins.

Authors:  A J Lusis; R West; M Mehrabian; M A Reuben; R C LeBoeuf; J S Kaptein; D F Johnson; V N Schumaker; M P Yuhasz; M C Schotz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  A partial cDNA clone for human apolipoprotein B.

Authors:  S S Deeb; A G Motulsky; J J Albers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

10.  Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.

Authors:  P Holvoet; G Perez; Z Zhao; E Brouwers; H Bernar; D Collen
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.